Skip to content

EW

Monitor

Edwards Lifesciences Corp

$86.92+1.16 (+1.35%)
Eldercare
Quality39/100

research_scan theme='longevity-aging'; value_chain_position='picks-and-shovels'; TAVR (transcatheter aortic valve replacement) franchise where >85% of patients are 65+; the demographic certainty + the procedure-shift away from open-heart surgery is one of the cleanest multi-decade demographic-coupled medical-device theses. Reservation-price advantage from regulatory-cleared multi-decade procedure shift; lower IRA-exposure than branded pharma.

Full research is one sign-in away

  • Verdict + reasoning
  • Falsification triggers
  • Financials
  • Price history
Sign in

General, impersonal research — never personalized advice.